Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (QoQ) (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.63% |
| Dec 31, 2024 | 66.02% |
| Sep 30, 2024 | -2,490.00% |
| Jun 30, 2024 | 94.97% |
| Mar 31, 2024 | 99.48% |
| Dec 31, 2023 | 58.72% |
| Dec 31, 2021 | 39.71% |
| Sep 30, 2021 | 98.30% |
| Jun 30, 2021 | 42.11% |
| Mar 31, 2020 | -84.21% |
| Dec 31, 2019 | 527.28% |
| Sep 30, 2019 | 150.82% |
| Jun 30, 2019 | -195.04% |
| Mar 31, 2019 | -26.12% |
| Dec 31, 2018 | 86.67% |
| Sep 30, 2018 | 252.91% |
| Jun 30, 2018 | 84.44% |
| Mar 31, 2018 | -52,489.69% |
| Dec 31, 2017 | 303.73% |
| Sep 30, 2017 | -1,590.54% |